117 related articles for article (PubMed ID: 38492244)
1. Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway.
Zheng E; Chen Q; Xiao A; Luo X; Lu Q; Tian C; Liu H; Zhao J; Wei L; Yang P; Chen Y
Biochem Biophys Res Commun; 2024 May; 707():149781. PubMed ID: 38492244
[TBL] [Abstract][Full Text] [Related]
2. GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice.
Lu Z; Li Y; Syn WK; Li AJ; Ritter WS; Wank SA; Lopes-Virella MF; Huang Y
Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E30-E42. PubMed ID: 33103454
[TBL] [Abstract][Full Text] [Related]
3. ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy.
Tian Y; Yang B; Qiu W; Hao Y; Zhang Z; Yang B; Li N; Cheng S; Lin Z; Rui YC; Cheung OKW; Yang W; Wu WKK; Cheung YS; Lai PBS; Luo J; Sung JJY; Chen R; Wang HY; Cheng ASL; Yang P
Nat Commun; 2019 Jul; 10(1):3391. PubMed ID: 31358770
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production.
Li Y; Zhang L; Jiao J; Ding Q; Li Y; Zhao Z; Luo J; Chen Y; Ruan X; Zhao L
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166800. PubMed ID: 37423141
[TBL] [Abstract][Full Text] [Related]
6. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway.
Conde de la Rosa L; Garcia-Ruiz C; Vallejo C; Baulies A; Nuñez S; Monte MJ; Marin JJG; Baila-Rueda L; Cenarro A; Civeira F; Fuster J; Garcia-Valdecasas JC; Ferrer J; Karin M; Ribas V; Fernandez-Checa JC
J Hepatol; 2021 Jun; 74(6):1429-1441. PubMed ID: 33515644
[TBL] [Abstract][Full Text] [Related]
7. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
[TBL] [Abstract][Full Text] [Related]
8. Low-bone-mass phenotype of deficient mice for the cluster of differentiation 36 (CD36).
Kevorkova O; Martineau C; Martin-Falstrault L; Sanchez-Dardon J; Brissette L; Moreau R
PLoS One; 2013; 8(10):e77701. PubMed ID: 24204923
[TBL] [Abstract][Full Text] [Related]
9. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
10. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
Song Q; Zhang X; Liu W; Wei H; Liang W; Zhou Y; Ding Y; Ji F; Ho-Kwan Cheung A; Wong N; Yu J
J Hepatol; 2023 Dec; 79(6):1352-1365. PubMed ID: 37459922
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic cell-restricted deletion of CD36 reduces high-fat diet-induced macrophage infiltration and improves insulin signaling in adipose tissue.
Nicholls HT; Kowalski G; Kennedy DJ; Risis S; Zaffino LA; Watson N; Kanellakis P; Watt MJ; Bobik A; Bonen A; Febbraio M; Lancaster GI; Febbraio MA
Diabetes; 2011 Apr; 60(4):1100-10. PubMed ID: 21378177
[TBL] [Abstract][Full Text] [Related]
12. [KLF9 regulates hepatic lipid metabolism via inducing CD36 expression].
Zhou SS; Zhang YL; Chang YS
Sheng Li Xue Bao; 2021 Oct; 73(5):772-780. PubMed ID: 34708234
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast.
Tao X; He H; Peng J; Xu R; Fu J; Hu Y; Li L; Yang X; Feng X; Zhang C; Zhang L; Yu X; Shen A; Huang K; Fu Q
Pharmacol Res; 2022 Jan; 175():106004. PubMed ID: 34826603
[TBL] [Abstract][Full Text] [Related]
14. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
15. E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
González-Romero F; Mestre D; Aurrekoetxea I; O'Rourke CJ; Andersen JB; Woodhoo A; Tamayo-Caro M; Varela-Rey M; Palomo-Irigoyen M; Gómez-Santos B; de Urturi DS; Núñez-García M; García-Rodríguez JL; Fernández-Ares L; Buqué X; Iglesias-Ara A; Bernales I; De Juan VG; Delgado TC; Goikoetxea-Usandizaga N; Lee R; Bhanot S; Delgado I; Perugorria MJ; Errazti G; Mosteiro L; Gaztambide S; Martinez de la Piscina I; Iruzubieta P; Crespo J; Banales JM; Martínez-Chantar ML; Castaño L; Zubiaga AM; Aspichueta P
Cancer Res; 2021 Jun; 81(11):2874-2887. PubMed ID: 33771899
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.
Xu W; Zhang X; Wu JL; Fu L; Liu K; Liu D; Chen GG; Lai PB; Wong N; Yu J
J Hepatol; 2017 Aug; 67(2):310-320. PubMed ID: 28347804
[TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
[TBL] [Abstract][Full Text] [Related]
18. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
[TBL] [Abstract][Full Text] [Related]
19. Early-life stress perturbs the epigenetics of Cd36 concurrent with adult onset of NAFLD in mice.
Fu Q; Frick JM; O'Neil MF; Eller OC; Morris EM; Thyfault JP; Christianson JA; Lane RH
Pediatr Res; 2023 Dec; 94(6):1942-1950. PubMed ID: 37479748
[TBL] [Abstract][Full Text] [Related]
20. CD36 and DGAT2 facilitate the lipid-lowering effect of chitooligosaccharides
Shen X; Liang X; Ji X; You J; Zhuang X; Song Y; Yin H; Zhao M; Zhao L
Food Funct; 2021 Sep; 12(18):8681-8693. PubMed ID: 34351342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
